Literature DB >> 12528606

Effect of respiratory syncytial virus infection during early infancy on the ontogeny of cytokine immune responses.

Deborah A Gentile1, David P Skoner.   

Abstract

Recently, childhood asthma has been associated with an alarming rise in prevalence, morbidity, and mortality. Strong epidemiological evidence now links the development of childhood asthma with the persistence of T-helper lymphocyte type 2 (Th2) cytokine immune responses during early infancy. However, the ontogeny of human cytokine immune responses and the environmental factors influencing their development have not been fully elucidated. Several lines of evidence support the hypothesis that respiratory syncytial virus (RSV) infection during early infancy induces/amplifies the persistence of Th2 cytokine immune responses. Moreover, results from recent studies suggest that diminished interleukin (IL)-12 production by dendritic cells (DCs) is a potential mechanism by which RSV infection predisposes to the persistence of Th2 cytokine responses. Studies are needed to characterize the ontogeny of DC IL-12 production and Th cytokine responses during early infancy and to investigate the effect of RSV infection during early infancy on these responses. Results from such research may provide insight into the mechanism by which RSV infection may predispose to the development of childhood asthma. Moreover, they may result in the identification of potential strategies to attenuate or prevent the development of RSV infection and/or childhood asthma. Such strategies may include administration of IL-12 or manipulation of DC maturation or function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12528606

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  5 in total

1.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

2.  Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration.

Authors:  Sihyug Jang; Joost Smit; Lara E Kallal; Nicholas W Lukacs
Journal:  J Leukoc Biol       Date:  2013-01-04       Impact factor: 4.962

3.  Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.

Authors:  Joost J Smit; Louis Boon; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

4.  Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis.

Authors:  A Gagro; M Tominac; V Krsulović-Hresić; A Baće; M Matić; V Drazenović; G Mlinarić-Galinović; E Kosor; K Gotovac; I Bolanca; S Batinica; S Rabatić
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 5.  Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update.

Authors:  Yaneisi Vázquez; Liliana González; Loreani Noguera; Pablo A González; Claudia A Riedel; Pablo Bertrand; Susan M Bueno
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.